Other languages Evolus, Inc.

Equities

EOLS

US30052C1071

Market Closed - Nasdaq Other stock markets 02:00:01 04/05/2024 am IST			5-day change	1st Jan Change
13.3 ^USD	+0.61%		+16.36%	+26.31%

26/04	AbbVie raises annual profit forecast on strong Skyrizi sales	RE
17/04	Evolus, Inc. Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra- Strength" 40U Formulation of Jeuveau	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AbbVie raises annual profit forecast on strong Skyrizi sales	26/04
Evolus, Inc. Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra- Strength" 40U Formulation of Jeuveau	18/04
Evolus, Inc. Announces Board Changes	04/04
Evolus Insider Sold Shares Worth $1,344,604, According to a Recent SEC Filing	22/03
Evolus Prices $50 Million Share Offering	11/03
Sector Update: Health Care Stocks Steady Pre-Bell Friday	08/03
Evolus Q4 Net Loss Narrows, Revenue Increases; 2024 Revenue Guidance Affirmed; Shares Fall After Hours	08/03
Evolus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Evolus, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/03
Evolus, Inc. Reiterates Earnings Guidance for the Full Year 2024	08/03
AbbVie profit beats estimates as Humira, Botox sales weather hit from rivals	02/02
Sector Update: Health Care Stocks Stronger Late Afternoon	30/01
Evolus Shares Rise After Upgrade From Barclays	30/01
Sector Update: Health Care Stocks Decline Pre-Bell Wednesday	17/01
Evolus Reports Higher Q4, 2023 Preliminary Revenue, Expects 2024 Revenue to Rise as Much as 31%; Shares Climb	17/01
Evolus, Inc. Announces Earnings Guidance for 2024	17/01
Evolus, Inc. Appoints Nareg Sagherian as Head of Global Investor Relations and Corporate Communications	05/01
Evolus Signs Licensing Deal With Symatese to Distribute Dermal Fillers in UK, Europe	21/12
Evolus, Inc. Enters into Licensing Agreement with Symatese to Exclusively Distribute Next Generation Dermal Fillers in Europe	20/12
US Consumer Advocacy Group Seeks to Strengthen Warnings on Botox Labeling	12/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Evolus, Inc.

Equities

EOLS

US30052C1071

Other languages

Filters